Story

Nestlé to Divest Mainstream Vitamin Brands to Yellow Wood Partners for $1 Billion

ENTHMSVIIDZHZH-TWJAKOHI
Sep 1, 20261 min read
Nestlé to Divest Mainstream Vitamin Brands to Yellow Wood Partners for $1 Billion
Text size
Background

Nestlé has agreed to sell its mainstream vitamins, minerals, and supplements business to private equity firm Yellow Wood Partners in a deal valued at $1.0 billion. The transaction marks a significant step in the consumer goods giant's ongoing effort to streamline its portfolio and concentrate on higher-growth categories.

Deal Details

The divested unit, which Nestlé refers to as its Holistic Health portfolio, generated sales of $1.2 billion in 2025. The sale is expected to close in the first half of 2027, pending customary regulatory approvals.

The agreement encompasses a wide range of well-known brands and assets, including:

  • Key Brands: Nature’s Bounty, Osteo Bi-Flex, Puritan’s Pride, Ester-C, Nuun, Gard, and Sisu.
  • Additional Assets: A U.S.-based private-label supplements business, along with associated manufacturing, packaging, and distribution facilities.

Strategic Rationale

Sample IUX Markets – In-articleAd

Nestlé framed the sale as a strategic move to sharpen its focus on the premium segment of the health and wellness market. The company will retain its science-led, premium brands, such as Solgar and Pure Encapsulations, which it noted continue to perform strongly.

"This is another important step in the strategic transformation of our portfolio," said Philipp Navratil, CEO of Nestlé, in a statement. "We are focusing our resources where we have the strongest competitive advantage." He added that the mainstream vitamin business has evolved and "requires a different approach under dedicated ownership."

Market Implications

This divestment is consistent with a broader trend among large multinational corporations to shed non-core or slower-growing assets to improve margins and reallocate capital. For investors, the sale signals Nestlé's commitment to prioritizing its premium and science-backed health nutrition brands, where it sees greater potential for innovation and growth. The transaction allows the company to concentrate its brand-building capabilities on a more focused set of high-value products.

Read next

More on Stocks
Back to latest news

LATEST